Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol DEK contributors: mct/pgu - updated : 07-02-2018
HGNC name DEK oncogene
HGNC id 2768
ASSOCIATED DISORDERS
corresponding disease(s) DEK
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in hepatocellular carcinoma
tumoral     --over  
in many solid tumors such as colon cancer, larynx cancer, bladder cancer, and melanoma
tumoral fusion translocation    
t(6;9) chromosomal translocation associated with a subtype of acute myelogenous leukemia (AML), which results in the formation of a DEK-NUP214 fusion protein
tumoral     --over gain of function
in retinoblastoma
tumoral     --over  
overexpression in pancreatic ductal adenocarcinoma (PDAC) was correlated with tumor size, histological grade, tumor&8209;node&8209;metastasis (TNM) stage and overall survival (OS) rates
Susceptibility
Variant & Polymorphism
Candidate gene
  • detection of DEK protein expression should be useful for the diagnosis and prognosis of ovarian serous cancer
  • may be a potential biomarker for poor prognostic evaluation in PDAC
  • Marker
    Therapy target
    SystemTypeDisorderPubmed
    neurologyataxia 
    able to partially reverse the mutation-prone phenotype of cells from patients with ataxia telangiectasia
    cancerreproductiveovary
    might be a useful molecular target for ovarian cancer therapy
    cancer  
    targeted suppression of DEK may become a strategic approach to the treatment of cancer
    cancerbrain 
    can be used as a potential target for astrocytic tumor gene therapy
    ANIMAL & CELL MODELS